Palexia 50 mg
Palexia 50 mg is a medicine authorised by Swissmedic under authorisation number 60530. The authorisation holder is Grünenthal Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A+: Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material. First authorisation was granted on 22 February 2011 and the authorisation is valid without a time limit. ATC code N02AX06 places the medicine in the group Analgesics.
| Authorisation number | 60530 |
|---|---|
| Name | Palexia 50 mg |
| Full name | Palexia 50 mg, Filmtabletten |
| Authorisation holder | Grünenthal Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A+ · Prescription with conditions |
| ATC code | N02AX06 |
| First authorisation | 22 February 2011 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Palexia 50 mg, Filmtabletten | A+ | 22 February 2011 |
| 2 | Palexia 75 mg, Filmtabletten | A+ | 22 February 2011 |
| 3 | Palexia 100 mg, Filmtabletten | A+ | 22 February 2011 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 20 | Tablette(n) | N02AX06 | 01.01.3. | A+ |
| 3 | 60 | Tablette(n) | N02AX06 | 01.01.3. | A+ |
| 6 | 20 | Tablette(n) | N02AX06 | 01.01.3. | A+ |
| 7 | 60 | Tablette(n) | N02AX06 | 01.01.3. | A+ |
| 14 | 20 | Tablette(n) | N02AX06 | 01.01.3. | A+ |
| 15 | 60 | Tablette(n) | N02AX06 | 01.01.3. | A+ |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Palexia 50 mg authorised in Switzerland?
Yes. Palexia 50 mg is authorised by Swissmedic under authorisation number 60530, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Palexia 50 mg have?
Palexia 50 mg is in dispensing category A+. Supplied only against a single-use prescription with additional Swissmedic conditions, for example narcotics or medicines with mandatory educational material.
Who is the authorisation holder of Palexia 50 mg?
The authorisation holder is Grünenthal Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.